Peer-reviewedCC BY-NC-NDTranslational pediatrics
Pharmacological treatment of patent ductus arteriosus: lessons from recent randomized trials.
- 1Division of Neonatology, MosaKids Children's Hospital, Maastricht University Medical Center (MUMC+), Research Institute for Oncology and Reproduction (GROW), Maastricht University, Maastricht, The Netherlands.
- 2Department of Pediatrics, Hospital Universitario Materno-Infantil de Canarias, Las Palmas de Gran Canaria, Spain.
Related
- Mortality and clinical outcomes in preterm infants with patent ductus arteriosus according to pharmacological treatment or expectant management: a retrospective cohort study.
- Outcomes associated with surgical ligation versus medical treatment for patent ductus arteriosus in extremely preterm infants
- Evolution of treatment strategies and risk-stratified management of patent ductus arteriosus in preterm infants
- Absent right pulmonary artery with patent ductus arteriosus and Eisenmenger syndrome
- Anomalous Origin of the Right Pulmonary Artery from the Ascending Aorta in an Adult After Prior Patent Ductus Arteriosus Surgery
BibTeX
@article{villamor2026pharmacological,
title = {{Pharmacological treatment of patent ductus arteriosus: lessons from recent randomized trials.}},
author = {Eduardo Villamor and Gloria Galán-Henríquez and Gema E Gonzalez-Luis},
journal = {Translational pediatrics},
year = {2026},
month = oct,
doi = {10.21037/tp-2026-0895},
url = {https://europepmc.org/article/MED/42996404},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Pharmacological treatment of patent ductus arteriosus: lessons from recent randomized trials.
AU - Eduardo Villamor
AU - Gloria Galán-Henríquez
AU - Gema E Gonzalez-Luis
PY - 2026
DA - 2026/10/22
JO - Translational pediatrics
DO - 10.21037/tp-2026-0895
UR - https://europepmc.org/article/MED/42996404
SN - 2224-4336
SN - 2224-4344
ER -